OncoResponse
Research
609 Main Street
11 employees
- Employees
- 11
- Contacts
- 4
- Emails
- 4
- Phones
- 4
OncoResponse Overview
- Headquarters
- 609 Main Street
- Website
- oncoresponse.com
- Industry
- Research
- Employees
- 11
- Founded
- 2016
Keywords
About OncoResponse
OncoResponse is a clinical stage, privately held immuno-oncology biotech company developing cancer immunotherapies using clues from the immune systems of elite cancer responders. In a broad strategic alliance with MD Anderson Cancer Center, OncoResponse deploys a proprietary B-cell discovery platform to identify and develop novel therapeutics targeting the tumor microenvironment. The company’s lead candidate, OR2805, has entered clinical studies with a unique and transformative approach to the advancement of cancer therapeutics. OncoResponse is based in Houston, Texas and Seattle, Washington.
OncoResponse Contact Details
- People in AeroLeads
- 4
- With contact data
- 4
- Email contacts
- 4
- 100.0% coverage
- Phone contacts
- 4
- 100.0% coverage
OncoResponse Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Clifford Stocks | Chief Executive Officer | Seattle, Washington, United States |
Email
Phone
|
| Kamal D. Puri | Chief Scientific Officer | Greater Seattle Area, United States |
Email
Phone
|
| Dr Alice Bexon | CEO Bexon Clinical and Leader at Ectd | Montclair, New Jersey, United States |
Email
Phone
|
| Chris Russell | Chief Financial Officer at Oncoresponse | Seattle, Washington, United States |
Email
Phone
|
Employees by Management Level
Executive
4 profiles
Compare Similar Companies to OncoResponse
Seagen
Biotechnology Research
ImmunityBio, Inc.
Biotechnology Research
Umoja Biopharma
Biotechnology Research
Immunome, Inc.
Biotechnology Research
CG Oncology
Biotechnology Research
IPA (ImmunoPrecise Antibodies)
Biotechnology Research
Notch Therapeutics
Biotechnology Research
PAI LIFE SCIENCES INC.
Biotechnology Research
Ignyte Bio
Biotechnology Research
MorphImmune
Biotechnology Research